NOVARTIS AG (NVS) reporting calendar
NOVARTIS AG files periodic reports with the SEC as NVS on NYSE. Atlas tracks 17 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 4 Feb 2026
- Reports on record
- 17
Open NVS market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 4 Feb 2026 | 35 days | 0001114448-26-000004 |
| 20-F | 31 Dec 2024 | 31 Jan 2025 | 31 days | 0001370368-25-000004 |
| 20-F | 31 Dec 2023 | 31 Jan 2024 | 31 days | 0001370368-24-000004 |
| 20-F | 31 Dec 2022 | 1 Feb 2023 | 32 days | 0001370368-23-000006 |
| 20-F | 31 Dec 2021 | 2 Feb 2022 | 33 days | 0001370368-22-000010 |
| 20-F | 31 Dec 2020 | 26 Jan 2021 | 26 days | 0001370368-21-000006 |
| 20-F | 31 Dec 2019 | 29 Jan 2020 | 29 days | 0001370368-20-000003 |
| 20-F | 31 Dec 2018 | 30 Jan 2019 | 30 days | 0001370368-19-000002 |
| 20-F | 31 Dec 2017 | 24 Jan 2018 | 24 days | 0001047469-18-000380 |
| 20-F | 31 Dec 2016 | 25 Jan 2017 | 25 days | 0001047469-17-000338 |
| 20-F | 31 Dec 2015 | 27 Jan 2016 | 27 days | 0001047469-16-009872 |
| 20-F | 31 Dec 2014 | 27 Jan 2015 | 27 days | 0001047469-15-000433 |
| 20-F | 31 Dec 2013 | 29 Jan 2014 | 29 days | 0001047469-14-000415 |
| 20-F | 31 Dec 2012 | 23 Jan 2013 | 23 days | 0001047469-13-000377 |
| 20-F | 31 Dec 2011 | 25 Jan 2012 | 25 days | 0001047469-12-000354 |
| 20-F | 31 Dec 2010 | 27 Jan 2011 | 27 days | 0001047469-11-000325 |
| 20-F | 31 Dec 2009 | 26 Jan 2010 | 26 days | 0001047469-10-000310 |
Source: SEC EDGAR company submissions for CIK 0001114448. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.